ABBV-8E12

AbbVie scraps an anti-tau study, and that may foretell more big trouble for a beleaguered Biogen
Endpoints
Fri, 07/26/19 - 11:00 am
AbbVie
Biogen
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
Xtalks
Fri, 01/27/17 - 09:30 am
AbbVie
clinical trials
anti-tau antibodies
Alzheimer's disease
ABBV-8E12
FDA grants AbbVie's anti-tau drug orphan status
BioPharma Dive
Mon, 07/20/15 - 11:07 am
FDA
AbbVie
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
C2N Diagnostics